0000070318false00000703182024-05-222024-05-220000070318us-gaap:CommonStockMemberexch:XNYS2024-05-222024-05-220000070318exch:XNYSus-gaap:SeniorNotesMember2024-05-222024-05-22


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 _______________
FORM 8-K
 _______________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report: May 22, 2024
(Date of earliest event reported)
 _______________
TENET HEALTHCARE CORPORATION
(Exact name of registrant as specified in its charter)
 
Nevada
 1-7293 95-2557091
(State of Incorporation) (Commission File Number) (IRS Employer
Identification Number)
14201 Dallas Parkway
Dallas, TX 75254
(Address of principal executive offices, including zip code)
(469) 893-2200
(Registrant’s telephone number, including area code)
 _______________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading
Symbol(s)		Name of each exchange
on which registered
Common stock, $0.05 par valueTHCNYSE
6.875% Senior Notes due 2031THC31NYSE
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
    Emerging Growth Company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     ☐

Item 5.07.
Submission of Matters to a Vote of Security Holders.
The 2024 Annual Meeting of Shareholders (the “Annual Meeting”) of Tenet Healthcare Corporation (the “Company”) was held on May 22, 2024. Below are the final voting results from the meeting.

1.    The Company’s shareholders elected the following directors to serve on the Company’s Board of Directors, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected or qualified, whichever is later, or until the director’s earlier resignation or removal:
FOR
AGAINST
ABSTAIN
BROKER
NON-VOTES
Saumya Sutaria
78,408,106 2,952,599 32,017 7,127,343 
J. Robert Kerrey
79,073,669 2,287,690 31,364 7,127,343 
Vineeta Agarwala81,165,083 196,130 31,509 7,127,343 
James L. Bierman
80,681,369 679,552 31,802 7,127,343 
Roy Blunt80,901,184 459,196 32,343 7,127,343 
Richard W. Fisher
80,876,576 483,410 32,737 7,127,343 
Meghan M. FitzGerald
79,983,800 1,373,328 35,595 7,127,343 
Cecil D. Haney
80,749,317 612,662 30,744 7,127,343 
Christopher S. Lynch
80,998,870 361,100 32,753 7,127,343 
Richard J. Mark
80,881,920 478,921 31,882 7,127,343 
Tammy Romo
80,830,618 530,853 31,252 7,127,343 
Stephen H. Rusckowski81,110,163 250,471 32,089 7,127,343 
Nadja Y. West
80,637,096 723,225 32,401 7,127,343 

2.    The Company’s shareholders approved, on an advisory basis, the Company’s executive compensation:

FOR
AGAINST
ABSTAIN
BROKER
NON-VOTES
78,324,1542,920,906147,6627,127,343 

3.    The Company’s shareholders approved the ratification of the selection of Deloitte & Touche LLP as the Company’s independent registered public accountants for the year ending December 31, 2024:

FOR
AGAINST
ABSTAIN
BROKER
NON-VOTES
87,988,280496,79034,996—

4.    The shareholder proposal requesting a report on risk mitigation regarding state restrictions for emergency abortions did not pass.

FOR
AGAINST
ABSTAIN
BROKER
NON-VOTES
4,059,52575,912,0771,421,1207,127,343

5.    The shareholder proposal requesting a report on plans to integrate ESG metrics into executive compensation did not pass.

FOR
AGAINST
ABSTAIN
BROKER
NON-VOTES
4,328,82176,596,569467,3327,127,343



SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

TENET HEALTHCARE CORPORATION
Date: May 23, 2023By:
/s/ THOMAS ARNST
Name: Thomas Arnst
Title: Executive Vice President, Chief Administrative Officer, General Counsel and Corporate Secretary

v3.24.1.1.u2
Document and Entity Information Document
May 22, 2024
Entity Information [Line Items]  
Document Type 8-K
Document Period End Date May 22, 2024
Entity Registrant Name TENET HEALTHCARE CORP
Entity Incorporation, State or Country Code NV
Entity File Number 1-7293
Entity Tax Identification Number 95-2557091
Entity Address, Address Line One 14201 Dallas Parkway
Entity Address, City or Town Dallas
Entity Address, State or Province TX
Entity Address, Postal Zip Code 75254
City Area Code 469
Local Phone Number 893-2200
Written Communications false
Soliciting Material false
Pre-commencement Issuer Tender Offer false
Pre-commencement Tender Offer false
Entity Emerging Growth Company false
Entity Central Index Key 0000070318
Amendment Flag false
New York Stock Exchange | Common Stock [Member]  
Entity Information [Line Items]  
Title of 12(b) Security Common stock, $0.05 par value
Trading Symbol THC
Security Exchange Name NYSE
New York Stock Exchange | 6.875% Senior Notes due 2031  
Entity Information [Line Items]  
Title of 12(b) Security 6.875% Senior Notes due 2031
Trading Symbol THC31
Security Exchange Name NYSE
Tenet Healthcare (NYSE:THC)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Tenet Healthcare Charts.
Tenet Healthcare (NYSE:THC)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Tenet Healthcare Charts.